Adaptive Biotechnologies Corporation
NASDAQAdaptive Biotechnologies heads into the final days of June with a telling split: options traders are as bullish as they've been all year, yet insiders have been quietly selling into the rally. The options market is the loudest signal this week. The put/call ratio has collapsed to 0.14 — near its 52-week low of 0.07 and almost 1.5 standard deviations below its 20-day average of…
Snapshot as of 22 Jun 2026
Adaptive Biotechnologies heads into the final days of June with a telling split: options traders are as bullish as they've been all year, yet insiders have been quietly selling into the rally. The options market is the…
Adaptive Biotechnologies enters the post-earnings period with a notable internal tension: short sellers are stepping back, yet the company's own President and COO has been selling shares every single trading day for…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ADPT — free to start on ORTEX.
Sign up for free →Open ADPT on ORTEX